BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 27645313)

  • 1. Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1.
    Patrick NM; Griggs CA; Icenogle AL; Gilpatrick MM; Kadiyala V; Jaime-Frias R; Smith CL
    J Steroid Biochem Mol Biol; 2017 Mar; 167():1-13. PubMed ID: 27645313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class I lysine deacetylases facilitate glucocorticoid-induced transcription.
    Kadiyala V; Patrick NM; Mathieu W; Jaime-Frias R; Pookhao N; An L; Smith CL
    J Biol Chem; 2013 Oct; 288(40):28900-12. PubMed ID: 23946490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of histone deacetylases in embryonic development.
    Dsilva P; Pai P; Shetty MG; Babitha KS
    Mol Reprod Dev; 2023 Jan; 90(1):14-26. PubMed ID: 36534913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.
    Lan F; Collins RE; De Cegli R; Alpatov R; Horton JR; Shi X; Gozani O; Cheng X; Shi Y
    Nature; 2007 Aug; 448(7154):718-22. PubMed ID: 17687328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.
    Seok YM; Lee HA; Park KM; Hwangbo MH; Kim IK
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):799-808. PubMed ID: 27106211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
    Metzger E; Imhof A; Patel D; Kahl P; Hoffmeyer K; Friedrichs N; Müller JM; Greschik H; Kirfel J; Ji S; Kunowska N; Beisenherz-Huss C; Günther T; Buettner R; Schüle R
    Nature; 2010 Apr; 464(7289):792-6. PubMed ID: 20228790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.
    Zhu Q; Liu C; Ge Z; Fang X; Zhang X; Strååt K; Björkholm M; Xu D
    PLoS One; 2008 Jan; 3(1):e1446. PubMed ID: 18197256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GR and LSD1/KDM1A-Targeted Gene Activation Requires Selective H3K4me2 Demethylation at Enhancers.
    Clark EA; Wu F; Chen Y; Kang P; Kaiser UB; Fang R; Shi YG
    Cell Rep; 2019 Jun; 27(12):3522-3532.e3. PubMed ID: 31216473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
    Vasilatos SN; Katz TA; Oesterreich S; Wan Y; Davidson NE; Huang Y
    Carcinogenesis; 2013 Jun; 34(6):1196-207. PubMed ID: 23354309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
    Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
    Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine-specific demethylase 1 cooperates with BRAF-histone deacetylase complex 80 to enhance HIV-1 Tat-mediated transactivation.
    Liu Y; Zhou D; Qi D; Feng J; Liu Z; Hu Y; Shen W; Liu C; Kong X
    Virus Genes; 2018 Oct; 54(5):662-671. PubMed ID: 30105631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.
    Metzger E; Wissmann M; Yin N; Müller JM; Schneider R; Peters AH; Günther T; Buettner R; Schüle R
    Nature; 2005 Sep; 437(7057):436-9. PubMed ID: 16079795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition.
    Lin T; Ponn A; Hu X; Law BK; Lu J
    Oncogene; 2010 Sep; 29(35):4896-904. PubMed ID: 20562920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition.
    Luo H; Shenoy AK; Li X; Jin Y; Jin L; Cai Q; Tang M; Liu Y; Chen H; Reisman D; Wu L; Seto E; Qiu Y; Dou Y; Casero RA; Lu J
    Cell Rep; 2016 Jun; 15(12):2665-78. PubMed ID: 27292636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleosome Binding by the Lysine Specific Demethylase 1 (LSD1) Enzyme Enables Histone H3 Demethylation.
    Dhall A; Shelton PMM; Delachat AM; Leonen CJA; Fierz B; Chatterjee C
    Biochemistry; 2020 Jul; 59(27):2479-2483. PubMed ID: 32567837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of neuronal Lysine-Specific Demethylase 1LSD1/KDM1A impairs transcriptional repression by regulating interaction with CoREST and histone deacetylases HDAC1/2.
    Toffolo E; Rusconi F; Paganini L; Tortorici M; Pilotto S; Heise C; Verpelli C; Tedeschi G; Maffioli E; Sala C; Mattevi A; Battaglioli E
    J Neurochem; 2014 Mar; 128(5):603-16. PubMed ID: 24111946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation.
    Lee MG; Wynder C; Cooch N; Shiekhattar R
    Nature; 2005 Sep; 437(7057):432-5. PubMed ID: 16079794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.
    Shi Y; Lan F; Matson C; Mulligan P; Whetstine JR; Cole PA; Casero RA; Shi Y
    Cell; 2004 Dec; 119(7):941-53. PubMed ID: 15620353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation.
    Van Dyke MW
    ChemMedChem; 2014 Mar; 9(3):511-22. PubMed ID: 24449617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma.
    Amente S; Milazzo G; Sorrentino MC; Ambrosio S; Di Palo G; Lania L; Perini G; Majello B
    Oncotarget; 2015 Jun; 6(16):14572-83. PubMed ID: 26062444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.